retatrutide triple agonist glp-1 gip glucagon Retatrutide, a GIP, and receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA New obesity drugs are coming,

The trade-off is pill swallowing and a slightly higher chance of mild stomach upset on day one

This combination is gaining clinical interest as physicians look for evidence-based ways to help patients lose fat while protecting the muscle tissue that keeps metabolism functioning and physical performance intact

Retatrutide works through fundamentally different mechanisms than anabolic steroids

Brain Fog and Cognitive Fatigue: By physically blocking the NMDA receptor pore, magnesium prevents the calcium-induced excitotoxicity and neuroinflammation that damages neurons and clouds cognitive processing, allowing for clearer thinking and reduced mental fatigue

L-carnitine is a nutrient that helps convert fatty acids into energy

I think that this should not be about weight